Producing of pharmaceuticals is the main activity of AS Kevelt.
In 1996 manufacturing of pharmaceuticals was started with producing of Prostenoon Gel 1mg. It was the first pharmaceutical in Estonia produced in aseptic conditions. Hereafter preparations as Prostenoon Gel 2mg for inducing of labor, Vasostenoon 20µg/ml for peripheral cardiovascular treatment, Prostenoon inj. 1mg/ml for preparing of labor and Glaumax 50µg/ml for lowering the elevated intraocular pressure were added. In addition, we produce biological preparations Lariphan (induction coil of interferon, treatment of viral diseases, Marketing Authorisation Holder SIA "Vitesan") and Rigvir (treatment of melanoma, Marketing Authorisation Holder SIA "Latima").
Pharmaceuticals are registered in following states:
Glaumax - Latanoprost - treatment of glaucoma - Estonia
Prostenoon-Gel 1mg - Dinoprostone - inducing of labor, women's health - Estonia, Latvia, Russia
Prostenoon-Gel 2mg - Dinoprostone - inducing of labor, women's health - Estonia, Latvia
Prostenoon 1mg/ml - Dinoprostone - inducing of labor, women's health - Estonia
Vasostenoon 20µg/ml - Alprostadile - peripheral cardiovascular treatment - Estonia, Latvia
Lariphan - dsRNA - treatment of viral and oncological diseases - Latvia
Rigvir - ECHO-7 - treatment of melanoma - Latvia
AS Kevelt produces also - pure biochemicals, Eicosanoid hormones – for scientific research.
- freezing solutions and –systems of stem- and cord blood cells as medical equipment.
We plan to add broncho-alveolar lavage into our product portfolio (for pulmonary wash)
in short-run.
Since 1 of January 2008 GLAUMAX - pharmaceutical for glaucoma - is in the list of recompensable pharmaceuticals.
Manufacturing of pharmaceuticals takes place according to regulations of EU and GMP.
| 
